Neogen Reports Q2 Fiscal 2009 Results
Year-to-date net income for the first six months of Neogen’s 2009 fiscal year increased 22% to $7,634,000 from $6,265,000 in FY 2008, or to $0.51 per share in
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XYear-to-date net income for the first six months of Neogen’s 2009 fiscal year increased 22% to $7,634,000 from $6,265,000 in FY 2008, or to $0.51 per share in
“I speak for the full Board of Directors of Quidel Corporation in recognizing Caren Mason for the outstanding leadership and results she has delivered for Quidel,” said Mark
She will succeed Jacques Deforges, the company’s current vice-president and chief financial officer, who will leave the company to pursue other interests. Cheung graduated from the University of
CONMED Linvatec issued Medical Device Safety Alert letters to customers dated July 31, 2009 providing information on findings from the company’s ongoing continuous quality improvement process. Following discussions
“This latest distribution agreement with AXA Diagnostics marks Rosetta Genomics’ entry into Europe, and we are excited to have AXA as our first partner in this region,” noted
Cambus Medical currently employs 25 people at the Spiddal operation. The company recently extended the plant at Baile an tSagairt industrial estate, tripling its production capacity while providing
Under the terms of the agreement, Sepracor shareholders will receive $23 in cash for each share of Sepracor they own for a total transaction value of approximately $2.6
The team’s analysis of four microRNAs (miRNA) found in the blood plasma of pancreatic cancer patients is proof of principle to further develop a blood test for this